Neurocysticercosis arises when larvae of the pork tapeworm Taenia solium lodge in the brain after a person swallows eggs shed by a human carrier, most often through contaminated food or water. Where the larvae settle determines how sick the patient becomes. When cysts embed in the brain parenchyma, they typically cause seizures and headaches, symptoms that usually respond to antiepileptic drugs, analgesics, and anthelmintic therapy, and the illness often follows a relatively benign course. When the parasites instead float freely within the cerebrospinal fluid compartments, the ventricles and the subarachnoid space, the picture changes dramatically. This extraparenchymal form responds poorly to anthelmintic drugs and can produce vasculitis, disrupted fluid circulation, and raised intracranial pressure driven by hydrocephalus. Basal subarachnoid disease is regarded as the most lethal presentation, carrying high rates of mortality and neurological disability.

The therapeutic dilemma at the heart of extraparenchymal disease is that treatment itself can make things worse. When cysts begin to degenerate, they ignite a marked inflammatory response inside the fluid compartments of the brain. Corticosteroids are routinely deployed to suppress this inflammation and prevent catastrophic complications, yet the same drugs may blunt the effectiveness of cysticidal agents, protecting the host but also sheltering the parasite. Clinical recommendations for managing these patients rest on studies with limited levels of evidence, which is precisely why researchers have long sought laboratory models that faithfully recapitulate the anatomy and immunology of the human infection.

Several experimental platforms exist, built on different parasites, including Taenia solium, Taenia crassiceps, and Mesocestoides corti, and different hosts, ranging from monkeys and pigs to rats and mice. A rat model developed by the Cysticercosis Working Group in Peru uses intracranial injection of activated T. solium oncospheres and has the advantage of employing the very species that causes human disease, but harvesting oncospheres from patients with taeniasis is not always feasible. The Brazilian team, led by Sophia Rossi de Barros Almeida and Pedro Tadao Hamamoto Filho of Botucatu Medical School at São Paulo State University, instead exploited a model in which 50 intact T. crassiceps cysticerci, each roughly half a millimetre in diameter, are suspended in saline and injected through a 25-gauge needle into the cisterna magna of six-week-old Wistar rats, mostly males, anesthetized with a ketamine and xylazine mixture.

To validate disease induction and chart the distribution of cysts throughout the cerebrospinal fluid compartments, the investigators examined magnetic resonance images acquired on a 0.25-T scanner with 0.6-millimetre slice thickness and T2-weighted gradient-echo acquisition, performed between one and six months after inoculation. Ventricular enlargement was quantified using the frontal horn ratio, a standard human neuroradiological measure calculated by dividing the maximal width of the frontal horns of the lateral ventricles by the inner-table-to-inner-table cranial diameter at the same level, with values above 0.3 indicating hydrocephalus. Because the low-field equipment could not resolve individual cysts, the team treated enlarged cisterns as indirect evidence of cyst presence, an assumption grounded in their empirical experience of imaging followed by euthanasia and necropsy.

The results were unambiguous. Intracranial abnormalities appeared in 189 of the 300 animals, or 63.0 percent, in the form of ventricular enlargement, subarachnoid space enlargement, or both. More than 90 percent of the animals with abnormalities showed ventricular dilation, predominantly of the lateral ventricles. The cisterna magna was the most frequently affected compartment at 85.2 percent, followed by the supratentorial basal cisterns at 78.8 percent, peritruncal cisterns anterior to the brainstem, the region near the pineal gland, the spinal canal, and, less commonly, the cerebral convexity, where abnormal spaces were seen in 10.6 percent of cases. Cysts were also detected outside the skull entirely, burrowing into the subcutaneous tissue of the neck in 39.2 percent of infected animals, a reminder of the parasite’s remarkable migratory capacity.

The frontal horn ratio ranged from 0.28 to 0.92, with a mean of 0.62 plus or minus 0.13, roughly double the human threshold for hydrocephalus and a striking severity given the animals’ mild clinical impairment. Notably, the presence of cysts in any cerebrospinal fluid compartment was associated with higher frontal horn ratios, whereas subcutaneous cyst location made no difference to ventricular size, with mean ratios of 0.622 versus 0.616 and a non-significant p-value of 0.743. Eleven animals, or 5.8 percent, were judged infected despite the absence of ventricular enlargement; in these, cysts clustered in the subcutaneous tissue and the cisterna magna. Subcutaneous cysts were found in 39.2 percent of intracranially infected animals and 30.2 percent of noninfected animals, with no statistically significant difference between the groups, suggesting skin involvement alone does not predict brain disease.

The parallels with human imaging are what give the model its translational punch. In a clinical study cited by the authors, 86.1 percent of patients with extraparenchymal neurocysticercosis harbored cysts in the posterior fossa cisterns, figures that correspond almost exactly to the 85.2 percent cisterna magna involvement and 57.1 percent peritruncal involvement seen in the rats, an expected overlap given that cysts are injected directly into that compartment. More intriguingly, cysts were also identified within the ventricles and supratentorial cisterns of the animals, demonstrating that the parasites can migrate across different fluid compartments just as they do in humans. The model even reproduces spinal disease, an uncommon but feared manifestation of human cysticercosis in which subarachnoid cysts cause motor deficits, back pain, and hydrocephalus, offering a potential platform for studying spinal cord compression.

Mechanistically, the model captures both routes by which hydrocephalus develops in human disease. Direct injection of cysts into the subarachnoid space obstructs the outflow of cerebrospinal fluid from the fourth ventricle, while inflammation along the ependymal lining adds an additional block to absorption. Yet the inflammatory response in infected animals appears attenuated, probably through the action of regulatory T cells, mirroring the immune evasion that allows cysts to survive for years in patients. Only after anthelmintic treatment, and particularly in the absence of corticosteroid cover, does inflammation intensify, reproducing the clinical paradox in which therapy for humans can worsen hydrocephalus and intracranial hypertension. Earlier work from the same group showed that T. crassiceps cysts injected into the subarachnoid space of rats simulate the radiological and morphological features of racemose neurocysticercosis, the multiloculated, grape-like form of the disease.

The authors acknowledge the inherent limitation of using a parasite species that differs from the one responsible for human illness, since species-specific host responses may not be fully reproduced, and they concede that their low-field open MRI system could neither count cysts nor reliably distinguish enlarged cisterns from cyst presence, a distinction that in humans does not always correspond either. Even so, their findings are comparable to those obtained with a 7-Tesla scanner in an adapted version of the model, and the higher parasite burden used here, 50 versus 30 cysts, may explain the greater disease severity, particularly the pronounced hydrocephalus. Taken together, the neuroimaging evidence cements this rat model as a practical, reproducible, and ethically sustainable platform for preclinical testing of new anti-inflammatory schedules, optimized anthelmintic regimens, surgical adjuncts, and even vaccines, against a neglected but potentially eradicable disease that still burdens millions across Latin America, Asia, and Africa.

Subject of Research: Neuroimaging features of an experimental rat model of extraparenchymal neurocysticercosis

Article Title: Neuroimaging Features of an Experimental Model of Extraparenchymal Neurocysticercosis

Article References: Almeida, S. R. D. B., Martins, T. D. C., Caldeira, F. M. C., Machado, V. M. D. V., Zanini, M. A., & Hamamoto Filho, P. T. (2026). Neuroimaging Features of an Experimental Model of Extraparenchymal Neurocysticercosis. Acta Parasitologica, 71(5), Article 200. https://doi.org/10.1007/s11686-026-01393-z

Image Credits: AI Generated

DOI: 10.1007/s11686-026-01393-z

Keywords: neurocysticercosis, Taenia crassiceps, hydrocephalus, MRI, experimental model, cerebrospinal fluid, frontal horn ratio, subarachnoid space, cisterna magna, Wistar rats, parasitic infection, neglected tropical disease

The subarachnoid space is best known as the layer between two protective membranes surrounding the brain and spinal cord. It contains cerebrospinal fluid, or CSF, which cushions the central nervous system and participates in the movement of nutrients, signaling molecules and waste products. Within this environment, arteries and veins travel along the brain’s surface and branch into deeper tissue. The spaces surrounding some of these vessels form specialized anatomical corridors that may influence fluid movement and communication between the brain’s vascular and fluid systems.

Researchers have long recognized that fluid does not circulate through the brain in a simple, open plumbing network. Instead, CSF moves through interconnected compartments, while blood vessels create boundaries and pathways that can shape local flow. Perivascular spaces are particularly important because they lie at the interface of vascular pulsation, tissue structure and fluid transport. Changes in their size, shape or visibility may reflect alterations in pressure, inflammation, vascular function or the clearance of metabolic waste.

The phrase “perivascular subarachnoid spaces” refers specifically to spaces associated with vessels in the subarachnoid compartment, rather than the more commonly discussed perivascular spaces located within the brain’s white matter and deep gray matter. Distinguishing these regions is technically important. Similar-looking spaces can arise in different anatomical locations and may have different biological meanings. A method that can reliably identify and characterize them could help researchers separate normal anatomical variation from changes linked to disease.

The study’s central significance lies in its non-invasive approach. Instead of relying on tissue removal or direct surgical access, non-invasive characterization generally uses advanced medical imaging and quantitative analysis to extract anatomical and physiological information from living participants. Imaging can reveal the geometry of fluid spaces, their relationship to nearby vessels and, in some circumstances, indirect signs of fluid movement. Such measurements are especially valuable for studying structures that are too small, delicate or inaccessible to investigate directly in routine clinical practice.

This type of research could also help clarify how the brain’s waste-clearance systems operate. The glymphatic system, a proposed network involving CSF and interstitial fluid, has attracted intense interest because it may help transport metabolic by-products away from neural tissue. Perivascular pathways are thought to be involved in this process, although their exact roles, direction of flow and relationship to other fluid compartments remain active areas of investigation. Better imaging of the spaces around surface vessels may provide data needed to test competing explanations rather than relying solely on theoretical models.

The potential medical relevance is broad. Disturbances in cerebrospinal-fluid dynamics and vascular function appear in conditions ranging from hydrocephalus and stroke to small-vessel disease, traumatic brain injury and neurodegenerative disorders. Enlarged or altered perivascular spaces have also been reported in association with aging and several brain diseases. However, an imaging finding is not automatically a diagnostic marker. Researchers must determine how much variation is normal, whether measurements are reproducible between scanners and observers, and whether changes in these spaces predict symptoms or clinical outcomes.

A reliable non-invasive method could eventually make it easier to compare the brain’s fluid compartments across individuals and over time. Longitudinal imaging might allow scientists to observe whether perivascular structures change with age, sleep, blood-pressure control or disease progression. It could also support studies of therapies designed to influence vascular pulsatility, CSF circulation or waste clearance. For now, the value of the work is primarily methodological: before a biological structure can become a biomarker, investigators need a consistent way to see and measure it.

The findings arrive at a moment when brain imaging is becoming increasingly quantitative. Modern scanners can generate high-resolution anatomical maps, while computational techniques can identify subtle structures and calculate their spatial relationships. Yet greater technical power also creates new challenges, including the risk of confusing imaging artifacts with anatomy and the danger of attaching biological meaning to patterns that have not been independently validated. Studies such as this one are therefore important not only because they highlight a hidden component of brain organization, but also because they help establish the measurement standards required for future research.

Perivascular subarachnoid spaces may sound like a specialized anatomical detail, but they sit at a potentially crucial crossroads linking blood vessels, cerebrospinal fluid and the brain’s protective membranes. By pursuing a non-invasive way to study them, Fultz, Ringstad, Debiasi and their colleagues are contributing to a broader effort to make the brain’s fluid circulation visible in living people. The approach does not yet transform these spaces into a clinical test, but it could provide researchers with a new tool for investigating how the brain maintains its internal environment—and what happens when that finely balanced system begins to fail.

Subject of Research: Non-invasive characterization of perivascular subarachnoid spaces in the human brain.

Article Title: Non-invasive characterization of perivascular subarachnoid spaces

Article References: Fultz, N.E., Ringstad, G., Debiasi, M. et al. “Non-invasive characterization of perivascular subarachnoid spaces.” Nature Communications (2026). https://doi.org/10.1038/s41467-026-76306-9

Image Credits: AI Generated

DOI: 10.1038/s41467-026-76306-9

Keywords: perivascular subarachnoid spaces, cerebrospinal fluid, brain imaging, neuroanatomy, vascular biology, glymphatic system, non-invasive research, neurological disease